Farmigea

Executive Summary

Farmigea is a privately held Italian pharmaceutical company established in 1946, with a specialized focus on ophthalmic products. The company operates as both a proprietary brand owner and a Contract Development and Manufacturing Organization (CDMO), providing sterile topical ophthalmic formulations. Its product portfolio spans pharmaceuticals, medical devices, and supplements for various eye conditions, serving a global market. With nearly 80 years of experience, Farmigea has built a strong reputation for quality and innovation in ophthalmology, leveraging its expertise in sterile manufacturing to serve both its own brands and third-party clients. The company's dual business model diversifies revenue streams and positions it well in the growing ophthalmic market, driven by aging populations and increasing prevalence of eye diseases.

Upcoming Catalysts (preview)

• Q3 2026Expansion of CDMO capacity with new sterile filling line80% success
• 2026Launch of a novel preservative-free artificial tears product in Europe65% success
• 2027Strategic partnership for US market distribution of existing product line50% success